Mariner, LLC

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1373442 Overland Park, KS

Position in IOVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,101,590

+$1,700,426 QoQ

Shares Held

505,190

+342.0% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 292 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mariner, LLC holds $490,050,155 across 152 Biotechnology names. IOVA ranks #24 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	608,615	$146,657,956
2	VRTX	Vertex Pharmaceuticals Inc / Ma	134,614	$66,866,811
3	REGN	Regeneron Pharmaceuticals, Inc.	100,086	$62,407,624
4	RPRX	Royalty Pharma plc	693,495	$38,884,263
5	EXEL	Exelixis, Inc.	313,083	$17,034,845
6	INCY	Incyte Corp	121,988	$13,828,559
7	BMRN	Biomarin Pharmaceutical Inc	192,607	$11,020,972
8	ALNY	Alnylam Pharmaceuticals, Inc.	28,021	$8,435,161

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,101,590	505,190	+342.0%	Shares	Sole	2026-08-13
2026-03-31	$401,164	114,292	+412.7%	Shares	Sole	2026-05-13
2025-09-30	$48,371	22,291	+40.0%	Shares	Sole	2025-11-14
2025-03-31	$53,020	15,922	-0.7%	Shares	Sole	2025-05-15
2024-12-31	$118,644	16,033	-13.4%	Shares	Sole	2025-02-13
2024-09-30	$173,865	18,516	-4.5%	Shares	Sole	2024-11-13
2024-06-30	$155,443	19,382	+16.3%	Shares	Sole	2024-08-13
2024-03-31	$246,901	16,660	+1.8%	Shares	Sole	2024-05-15
2023-12-31	$133,112	16,373	-95.6%	Shares	Sole	2024-02-14
2023-09-30	$1,691,917	371,850	+107.3%	Shares	Sole	2023-11-13
2023-06-30	$1,262,976	179,400	+67.2%	Shares	Sole	2023-08-11
2023-03-31	$655,603	107,300	+71.1%	Shares	Sole	2023-05-15
2022-12-31	$400,653	62,700	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.